109 related articles for article (PubMed ID: 3703321)
1. [Possible therapeutic uses of lactulose other than in porto-systemic encephalopathy].
Alvaro D; Angelico M; Attili AF
Minerva Dietol Gastroenterol; 1986; 32(1):67-72. PubMed ID: 3703321
[No Abstract] [Full Text] [Related]
2. [Lactulose in the therapy of porto-systemic encephalopathy].
Almici C; Inzoli MR; Poloni AE; Zambruni A
Minerva Med; 1973 Dec; 64(87):4596-603. PubMed ID: 4774227
[No Abstract] [Full Text] [Related]
3. [Comparative study of lactulose and neomycin in the treatment of porto-systemic encephalopathy].
Sala Felis T; Berenguer J; Barrios JM; Gómez J
Rev Esp Enferm Apar Dig; 1974 Feb; 42(3):335-42. PubMed ID: 4829021
[No Abstract] [Full Text] [Related]
4. [Intestine and liver-protective therapy].
Kremer H
Z Allgemeinmed; 1974 Oct; 50(28):1252-5. PubMed ID: 4446643
[No Abstract] [Full Text] [Related]
5. [Lactulose in the treatment of hepatic (pre)coma].
Grijm R
Ned Tijdschr Geneeskd; 1978 Feb; 122(6):198-200. PubMed ID: 24187
[No Abstract] [Full Text] [Related]
6. The use of lactulose in portal-systemic encephalopathy.
Matthews SJ
Conn Med; 1978 Feb; 42(2):96-7. PubMed ID: 630868
[No Abstract] [Full Text] [Related]
7. Portal systemic encephalopathy--should lactulose and neomycin be used together.
Martin AJ
Br J Clin Pract; 1981 Sep; 35(9):323-4. PubMed ID: 7326185
[No Abstract] [Full Text] [Related]
8. [Guidelines for Laevolac therapy against the endogenous factor in periodontal diseases].
Ebner N
Osterr Z Stomatol; 1978 Sep; 75(9):327-31. PubMed ID: 33356
[No Abstract] [Full Text] [Related]
9. Prevention of cholesterol gallstones by lignin and lactulose in the hamster.
Rotstein OD; Kay RM; Wayman M; Strasberg SM
Gastroenterology; 1981 Dec; 81(6):1098-103. PubMed ID: 6269949
[TBL] [Abstract][Full Text] [Related]
10. [Lactulose (Bifiteral)--a physiologically active intestinal agent for constipation, Salmonella and hepatic encephalopathy].
Fortschr Med; 1982 Nov; 100(44):2059-60. PubMed ID: 7173786
[No Abstract] [Full Text] [Related]
11. [Controlled clinical study of a new preparation for the treatment of digestive disorders].
Mereto GC
Minerva Gastroenterol; 1975; 21(1):31-4. PubMed ID: 1207938
[No Abstract] [Full Text] [Related]
12. Lactulose for hepatic encephalopathy.
Med Lett Drugs Ther; 1976 Jan; 18(1):3-4. PubMed ID: 1105127
[No Abstract] [Full Text] [Related]
13. Lactulose as an anti-endotoxin in liver transplantation.
Lancet; 1989 Oct; 2(8668):927-8. PubMed ID: 2571854
[No Abstract] [Full Text] [Related]
14. [Treatment of hepatic encephalopathy with lactulose].
Veljkov N; Kulenović S; Borovac N; Rezaković D
Med Arh; 1981; 35(5-6):267-9. PubMed ID: 7345270
[No Abstract] [Full Text] [Related]
15. [Use of lactulose (Amivalex) in the treatment of Salmonella excretors].
Barna M; Ferencz A; Bene M; Tóth A; Bán E
Orv Hetil; 1984 Dec; 125(52):3169-71. PubMed ID: 6397707
[No Abstract] [Full Text] [Related]
16. [Lactulose and its derivatives--treatment of hepatic encephalopathy and other possible indications for its use].
Fehér J; Prónai L
Orv Hetil; 1993 Jun; 134(26):1417-9. PubMed ID: 8332363
[TBL] [Abstract][Full Text] [Related]
17. Some aspects of medical management of gastrointestinal disease. I.
Badley BW
Can Med Assoc J; 1975 Jan; 112(2):200-4, 206. PubMed ID: 234288
[TBL] [Abstract][Full Text] [Related]
18. Lactulose--a drug with antiendotoxin effect.
Liehr H; Englisch G; Rasenack U
Hepatogastroenterology; 1980 Oct; 27(5):356-60. PubMed ID: 7009359
[TBL] [Abstract][Full Text] [Related]
19. Lactulose (cephulac) in portosystemic encephalopathy.
Kosman ME
JAMA; 1976 Nov; 236(21):2444-5. PubMed ID: 989871
[TBL] [Abstract][Full Text] [Related]
20. [Treatment with lactulose. A low-risk alternative in various diseases].
Reim HG; Koken M
Fortschr Med; 1984 Dec; 102(45):1167-70. PubMed ID: 6394457
[No Abstract] [Full Text] [Related]
[Next] [New Search]
